# Biolargo, Inc.: filings

BLGO · OTC · CIK 880242 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blgo.md) · [Financials](/companies/blgo/financials.md) · [Filings](/companies/blgo/filings.md) · [Insiders](/companies/blgo/insiders.md)

## Reports and events: 239 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 434, 8-K 121, 10-Q 53, 424B4 31, EFFECT 31, POS AM 23, D 22, CORRESP 20, UPLOAD 19, 10-K 18, DEF 14A 16, 4/A 14, S-1 11, S-1/A 10, PRE 14A 7, D/A 6, NT 10-K 6, 10-Q/A 5, 3 5, 5 5, 10-K/A 3, DEF 14C 3, DEL AM 3, NT 10-Q 3, POS EX 3, SC 13G 2, 3/A 1, 8-K/A 1, DEFA14A 1, DEFA14C 1, NT 10-Q/A 1, PRER14A 1, RW 1, S-8 1, SC 13D 1, SEC ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 10:01 ET | [DEF 14A](/filings/0001437749-26-032868.md) | Proxy statement, period 2026-12-01 | 0001437749-26-032868 |
| 2026-09-14 | 23:42 ET | [8-K/A](/filings/0001437749-26-030198.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030198 |
| 2026-09-11 | 14:38 ET | [8-K](/filings/0001437749-26-030124.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030124 |
| 2026-08-14 | 20:27 ET | [10-Q](/filings/0001437749-26-028023.md) | Quarterly report, period 2026-06-30 | 0001437749-26-028023 |
| 2026-05-15 | 20:29 ET | [10-Q](/filings/0001437749-26-017391.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017391 |
| 2026-05-06 | 10:02 ET | [8-K](/filings/0001437749-26-014996.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014996 |
| 2026-05-04 | 11:30 ET | [8-K](/filings/0001437749-26-014540.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014540 |
| 2026-04-30 | 20:02 ET | [10-K/A](/filings/0001437749-26-014184.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-014184 |
| 2026-04-09 | 18:50 ET | [S-1](/filings/0001437749-26-011880.md) | Registration statement | 0001437749-26-011880 |
| 2026-04-09 | 18:35 ET | [S-1](/filings/0001437749-26-011875.md) | Registration statement | 0001437749-26-011875 |
| 2026-03-25 | 21:06 ET | [8-K](/filings/0001437749-26-009813.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-009813 |
| 2026-03-05 | 19:31 ET | [8-K](/filings/0001437749-26-007044.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-007044 |
| 2026-03-04 | 22:11 ET | [10-K](/filings/0001437749-26-006926.md) | Annual report, period 2025-12-31 | 0001437749-26-006926 |
| 2025-11-18 | 01:19 ET | [8-K](/filings/0001437749-25-035506.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-035506 |
| 2025-11-14 | 22:14 ET | [10-Q](/filings/0001437749-25-035239.md) | Quarterly report, period 2025-09-30 | 0001437749-25-035239 |
| 2025-11-14 | 21:25 ET | [8-K](/filings/0001437749-25-035203.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035203 |
| 2025-10-20 | 21:12 ET | [8-K](/filings/0001437749-25-031354.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-031354 |
| 2025-09-25 | 15:15 ET | [8-K](/filings/0001437749-25-029852.md) | 1.02 Termination of a material agreement; 2.06 Material impairments; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029852 |
| 2025-08-15 | 15:50 ET | [8-K](/filings/0001437749-25-027100.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027100 |
| 2025-08-14 | 21:17 ET | [10-Q](/filings/0001437749-25-027021.md) | Quarterly report, period 2025-06-30 | 0001437749-25-027021 |
| 2025-07-23 | 13:31 ET | [8-K](/filings/0001437749-25-023293.md) | 7.01 Regulation FD disclosure | 0001437749-25-023293 |
| 2025-06-25 | 21:08 ET | [8-K](/filings/0001437749-25-021276.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-021276 |
| 2025-05-15 | 21:11 ET | [8-K](/filings/0001437749-25-017258.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-017258 |
| 2025-05-15 | 20:30 ET | [10-Q](/filings/0001437749-25-017205.md) | Quarterly report, period 2025-03-31 | 0001437749-25-017205 |
| 2025-04-25 | 23:09 ET | [DEF 14A](/filings/0001437749-25-013006.md) | Proxy statement, period 2025-06-19 | 0001437749-25-013006 |
| 2025-03-31 | 21:29 ET | [8-K](/filings/0001437749-25-010296.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-010296 |
| 2025-03-31 | 19:57 ET | [10-K](/filings/0001437749-25-010172.md) | Annual report, period 2024-12-31 | 0001437749-25-010172 |
| 2024-11-15 | 11:01 ET | [8-K](/filings/0001437749-24-035426.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035426 |
| 2024-11-14 | 21:38 ET | [10-Q](/filings/0001437749-24-035345.md) | Quarterly report, period 2024-09-30 | 0001437749-24-035345 |
| 2024-08-15 | 23:47 ET | [8-K](/filings/0001437749-24-026919.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026919 |
| 2024-08-14 | 20:21 ET | [10-Q](/filings/0001437749-24-026827.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026827 |
| 2024-06-20 | 17:55 ET | [8-K](/filings/0001437749-24-020750.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-020750 |
| 2024-06-13 | 18:34 ET | [8-K](/filings/0001437749-24-020181.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020181 |
| 2024-05-15 | 10:02 ET | [8-K](/filings/0001437749-24-016762.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-016762 |
| 2024-05-14 | 20:51 ET | [10-Q](/filings/0001437749-24-016682.md) | Quarterly report, period 2024-03-31 | 0001437749-24-016682 |
| 2024-04-26 | 19:32 ET | [DEF 14A](/filings/0001437749-24-013406.md) | Proxy statement, period 2024-06-13 | 0001437749-24-013406 |
| 2024-04-12 | 21:16 ET | [S-1](/filings/0001437749-24-011927.md) | Registration statement | 0001437749-24-011927 |
| 2024-04-01 | 20:45 ET | [10-K](/filings/0001437749-24-010394.md) | Annual report, period 2023-12-31 | 0001437749-24-010394 |
| 2024-01-22 | 15:15 ET | [8-K](/filings/0001437749-24-001796.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001796 |
| 2024-01-10 | 17:12 ET | [8-K](/filings/0001437749-24-001078.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001078 |
| 2024-01-05 | 18:05 ET | [8-K](/filings/0001437749-24-000717.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-24-000717 |
| 2023-11-21 | 11:01 ET | [8-K](/filings/0001437749-23-032675.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-032675 |
| 2023-11-14 | 18:28 ET | [10-Q](/filings/0001437749-23-031874.md) | Quarterly report, period 2023-09-30 | 0001437749-23-031874 |
| 2023-10-04 | 17:33 ET | [8-K](/filings/0001437749-23-027617.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-027617 |
| 2023-08-14 | 20:57 ET | [10-Q](/filings/0001437749-23-023751.md) | Quarterly report, period 2023-06-30 | 0001437749-23-023751 |
| 2023-06-12 | 19:03 ET | [8-K](/filings/0001437749-23-017110.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-017110 |
| 2023-06-09 | 19:08 ET | [8-K](/filings/0001437749-23-017042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-017042 |
| 2023-06-06 | 17:34 ET | [8-K](/filings/0001437749-23-016721.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-016721 |
| 2023-05-18 | 20:56 ET | [8-K](/filings/0001437749-23-015141.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-015141 |
| 2023-05-17 | 13:15 ET | [10-Q](/filings/0001437749-23-014881.md) | Quarterly report, period 2023-03-31 | 0001437749-23-014881 |

Page 1 of 5. [Older](/companies/blgo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.